EVALUATION OF PATIENT AND PUBLIC INVOLVEMENT INITIATIVES IN HEALTH TECHNOLOGY ASSESSMENT: A SURVEY OF INTERNATIONAL AGENCIES

被引:34
|
作者
Weeks, Laura [1 ]
Polisena, Julie [1 ]
Scott, Anna Mae [2 ]
Holtorf, Anke-Peggy [3 ]
Staniszewska, Sophie [4 ]
Facey, Karen [5 ]
机构
[1] Canadian Agcy Drugs & Technol Hlth CADTH, Ottawa, ON, Canada
[2] Bond Univ, Ctr Res Evidence Based Practice, Southport, Qld, Australia
[3] Hlth Outcomes Strategies GmbH, Basel, Switzerland
[4] Univ Warwick, Coventry, W Midlands, England
[5] Univ Edinburgh, Edinburgh, Midlothian, Scotland
关键词
Patient involvement; Public involvement; Evaluation; PERSPECTIVES; DECISIONS; CONSUMERS; IMPACT; POLICY;
D O I
10.1017/S0266462317000976
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objectives: Although there is increased awareness of patient and public involvement (PPI) among health technology assessment (HTA) organizations, evaluations of PPI initiatives are relatively scarce. Our objective as members of Health Technology Assessment International's (HTAi's) Patient and Citizen Involvement Group (PCIG) was to advance understanding of the range of evaluation strategies adopted by HTA organizations and their potential usefulness. Methods: In March 2016, a survey was sent to fifty-four HTA organizations through the International Network of Agencies for Health Technology Assessment (INAHTA) and contacts of members of HTAi's PCIG. Respondents were asked about their organizational structure; how patients and members of the public are involved; whether and how PPI initiatives have been evaluated, and, if so, which facilitators and challenges to evaluation were found and how results were used and disseminated. Results: Fifteen (n = 15) programs from twelve countries responded (response rate 27.8 percent) that involved patients (14/15) and members of the public (10/15) in HTA activities. Seven programs evaluated their PPI activities, including participant satisfaction (5/7), process (5/7) and impact evaluations (4/7). Evaluation results were used to improve PPI activities, identify education and training needs, and direct strategic priorities. Facilitators and challenges revolved around the need for stakeholder buy-in, sufficient resources, senior leadership, and including patients in evaluations. Conclusions: A small but diverse set of HTA organizations evaluate their PPI activities using a range of strategies that reflect the range of rationales and approaches to PPI in HTA. It will be important for HTA organizations to draw on evaluation theories and methods.
引用
收藏
页码:715 / 723
页数:9
相关论文
共 50 条
  • [21] Recommendations for patient involvement in health technology assessment in Central and Eastern European countries
    Jakab, Ivett
    Dimitrova, Maria
    Houyez, Francois
    Bereczky, Tamas
    Fovenyes, Miroslava
    Maravic, Zorana
    Belina, Ivica
    Andriciuc, Christian
    Toth, Krisztina
    Piniazhko, Oresta
    Hren, Rok
    Gutierrez-Ibarluzea, Inaki
    Czech, Marcin
    Tesar, Tomas
    Niewada, Maciej
    Lorenzovici, Laszlo
    Kamusheva, Maria
    Manova, Manoela
    Savova, Alexandra
    Mitkova, Zornitsa
    Tachkov, Konstantin
    Nemeth, Bertalan
    Petyko, Zsuzsanna Ida
    Dawoud, Dalia
    Delnoij, Diana
    Knies, Saskia
    Goettsch, Wim
    Kalo, Zoltan
    FRONTIERS IN PUBLIC HEALTH, 2023, 11
  • [22] Patient involvement in relative effectiveness assessments in the European Network for Health Technology Assessment
    Elvsaas, Ida Kristin Orjasaeter
    Ettinger, Sabine
    Willemsen, Anne
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2021, 37 (01)
  • [23] As health technology assessment evolves so must its approach to patient involvement
    Facey, Karen M.
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2019, 8 (08) : 549 - 554
  • [24] EUPATI Guidance for Patient Involvement in Medicines Research and Development: Health Technology Assessment
    Hunter, Amy
    Facey, Karen
    Thomas, Victoria
    Haerry, David
    Warner, Kay
    Klingmann, Ingrid
    May, Matthew
    See, Wolf
    FRONTIERS IN MEDICINE, 2018, 5
  • [25] Acceptability and Perceived Benefits and Risks of Public and Patient Involvement in Health Care Policy: A Delphi Survey in Belgian Stakeholders
    Cleemput, Irina
    Christiaens, Wendy
    Kohn, Laurence
    Leonard, Christian
    Daue, Francois
    Denis, Alain
    VALUE IN HEALTH, 2015, 18 (04) : 477 - 483
  • [26] Integrating environmental sustainability into health technology assessment: an international survey of HTA stakeholders
    Bobini, Michela
    Cicchetti, Americo
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2024, 40 (01)
  • [27] Public and Patient Involvement at the UK National Institute for Health and Clinical Excellence
    Leela Barham
    The Patient: Patient-Centered Outcomes Research, 2011, 4 : 1 - 10
  • [28] Meaningful patient and public involvement in digital health innovation, implementation and evaluation: A systematic review
    Baines, Rebecca
    Bradwell, Hannah
    Edwards, Katie
    Stevens, Sebastian
    Prime, Samantha
    Tredinnick-Rowe, John
    Sibley, Miles
    Chatterjee, Arunangsu
    HEALTH EXPECTATIONS, 2022, 25 (04) : 1232 - 1245
  • [29] Health technology assessment to optimize health technology utilization: Using implementation initiatives and monitoring processes
    Fronsdal, Katrine B.
    Facey, Karen
    Klemp, Marianne
    Norderhaug, Inger Natvig
    Morland, Berit
    Rottingen, John-Arne
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2010, 26 (03) : 309 - 316
  • [30] Stories of Patient Involvement Impact in Health Technology Assessments: A Discussion Paper
    Single, Ann N. V.
    Facey, Karen M.
    Livingstone, Heidi
    Silva, Aline Silveira
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2019, 35 (04) : 266 - 272